The current opinion that obesity is associated with lower levels of circulating BDNF [11,19], and that restoring its physiological levels by administration of exogenous BDNF may prevent the detrimental effect of the metabolic syndrome [11] should be considered carefully. The gene discussed is BDNF; the disease is obesity due to melanocortin 4 receptor deficiency.